Ramucirumab Plus FOLFOX as Front-Line Treatment in Advanced Gastric Cancer
Dr. Bendell discusses the results of a randomized, double-blind, multicenter phase 2 trial that examined FOLFOX plus or minus ramucirumab as front-line therapy for advanced gastric or esophageal adeno...
Author: feeds
Added: 05/13/2015 (Source: Oncology Tube)
Source: Oncology Tube - May 13, 2015 Category: Cancer & Oncology Source Type: podcasts
Phase III Study of Apatinib in Gastric Cancer
Dr. Bendell discusses the randomized, double-blind, placebo-control trial of apatinib in advanced gastric cancer.
Johanna Bendell, MD, director of GI Cancer Research Program, associate director, Drug...
Author: onclivetv
Added: 05/08/2015 (Source: Oncology Tube)
Source: Oncology Tube - May 8, 2015 Category: Cancer & Oncology Source Type: podcasts
Hereditary Diffuse Gastric Cancer Syndrome (JAMA Oncology)
Interview with David Huntsman, MD and Samantha Hansford, BSc, authors of Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - February 12, 2015 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
JAMA Oncology : Hereditary Diffuse Gastric Cancer Syndrome
Interview with David Huntsman, MD and Samantha Hansford, BSc, authors of Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - February 12, 2015 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Anti-PD-L1 Boasts Benefit, Tolerability in Gastric Cancer
Dr Brandon Smaglo reports on 2 studies from 2015 GCIS, one showing benefit from pembrolizumab in gastric cancer, another suggesting that less palliative therapy may be warranted in esophageal cancer. (Source: Medscape Oncology)
Source: Medscape Oncology - February 3, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Pembrolizumab Boasts Benefit, Tolerability in Gastric Cancer
Dr Brandon Smaglo reports on 2 studies from 2015 GCIS, one showing benefit from pembrolizumab in gastric cancer, another suggesting that less palliative therapy may be warranted in esophageal cancer. (Source: Medscape Oncology)
Source: Medscape Oncology - February 3, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Helicobacter pylori - new evidence, and when to test and treat
Two articles on bmj.com look at helicobacter pylori; a systematic review and meta-analysis examines if eradication treatment reduces rates of gastric cancer, and an uncertainties article asks who we should be testing and treating for the infection.
Two of the authors of those articles, Alex Ford from the Leeds Gastroenterology Institute, and Paul Moayyedi from the Gastroenterology Division of McMaster University, join us to discuss the bacterium.
Read the full articles
www.bmj.com/content/348/bmj.g3174
www.bmj.com/content/348/bmj.g3320 (Source: The BMJ Podcast)
Source: The BMJ Podcast - May 27, 2014 Category: General Medicine Authors: BMJ Group Source Type: podcasts
Stupid stomach cancer
There are 22,000 diagnoses of Stomach Cancer each year, which a significant percentage increasing in young adults. Join is as we welcome Debbie Zelman (Founder, Debbie's Dream Foundation) and AYA stomach cancer survivor Jess Mac for an initiative conversation about this oft undiscussed disease. (Source: The Stupid Cancer Show - Blog Talk Radio)
Source: The Stupid Cancer Show - Blog Talk Radio - May 20, 2014 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts
STUPID STOMACH CANCER - Mai 20,2014
There are 22,000 diagnoses of Stomach Cancer each year, which a significant percentage increasing in young adults. Join is as we welcome Debbie Zelman (Founder, Debbie's Dream Foundation) and AYA stomach cancer survivor Jess Mac for an initiative conversation about this oft undiscussed disease. (Source: The Stupid Cancer Show - Blog Talk Radio)
Source: The Stupid Cancer Show - Blog Talk Radio - May 20, 2014 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts
Stupid stomach cancer - 五月 20,2014
There are 22,000 diagnoses of Stomach Cancer each year, which a significant percentage increasing in young adults. Join is as we welcome Debbie Zelman (Founder, Debbie's Dream Foundation) and AYA stomach cancer survivor Jess Mac for an initiative conversation about this oft undiscussed disease. (Source: The Stupid Cancer Show - Blog Talk Radio)
Source: The Stupid Cancer Show - Blog Talk Radio - May 20, 2014 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts
Stupid stomach cancer
There are 22,000 diagnoses of Stomach Cancer each year, which a significant percentage increasing in young adults. Join is as we welcome Debbie Zelman (Founder, Debbie's Dream Foundation) and AYA stomach cancer survivor Jess Mac for an initiative conversation about this oft undiscussed disease. (Source: The Stupid Cancer Show - Blog Talk Radio)
Source: The Stupid Cancer Show - Blog Talk Radio - May 20, 2014 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts
STUPID STOMACH CANCER - May 20,2014
There are 22,000 diagnoses of Stomach Cancer each year, which a significant percentage increasing in young adults. Join is as we welcome Debbie Zelman (Founder, Debbie's Dream Foundation) and AYA stomach cancer survivor Jess Mac for an initiative conversation about this oft undiscussed disease. (Source: The Stupid Cancer Show - Blog Talk Radio)
Source: The Stupid Cancer Show - Blog Talk Radio - May 15, 2014 Category: Cancer & Oncology Authors: Stupid Cancer Show Tags: Health Source Type: podcasts
Hard Evidence for Second-Line Chemo in Gastric Cancer
Dr. David Kerr reports on a Korean meta-analysis that clearly supports use of second-line chemotherapy in locally advanced or metastatic gastric cancer at the time of relapse. (Source: Medscape Gastroenterology Podcast)
Source: Medscape Gastroenterology Podcast - January 13, 2014 Category: Gastroenterology Authors: Medscape Source Type: podcasts
Spleen Preserving Radical Gastrectomy with D2 lymphadenectomy
The question how to operate gastric cancer is still very actual. In literature we can find many controversies about the volume of needed dissection. As I believe D2 LN dissection is very important to...
Author: ilyagotsadze
Added: 01/09/2014 (Source: Oncology Tube)
Source: Oncology Tube - January 9, 2014 Category: Cancer & Oncology Source Type: podcasts
